{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:17:49Z","timestamp":1791325069153,"version":"4.3.1"},"reference-count":19,"publisher":"American Chemical Society (ACS)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioconjugate Chem."],"published-print":{"date-parts":[[2014,10,15]]},"DOI":"10.1021\/bc500357n","type":"journal-article","created":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T14:12:14Z","timestamp":1412604734000},"page":"1871-1880","source":"Crossref","is-referenced-by-count":193,"title":["Mild Method for Succinimide Hydrolysis on ADCs: Impact on ADC Potency, Stability, Exposure, and Efficacy"],"prefix":"10.1021","volume":"25","author":[{"given":"L. Nathan","family":"Tumey","sequence":"first","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Charati","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sousa","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dangshe","family":"Ma","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Han","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Clark","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Casavant","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Loganzo","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Barletta","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Lucas","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund I.","family":"Graziani","sequence":"additional","affiliation":[{"name":"Worldwide Medicinal Chemistry, \u2021Global Biological Technologies, \u00a7Pharmacokinetics, Metabolism, and Distribution, and \u2225Oncology Research Unit, Pfizer Global R&D, Groton, Connecticut 06340, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"issue":"1","key":"ref1\/cit1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4161\/mabs.27436","volume":"6","author":"Beck A.","year":"2014","journal-title":"mAbs"},{"key":"ref2\/cit2a","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-541-5_1","volume":"1045","author":"Sassoon I.","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"ref2\/cit2b","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.drudis.2013.11.004","volume":"19","author":"Perez H. L.","year":"2014","journal-title":"Drug Discovery Today"},{"issue":"2","key":"ref3\/cit3a","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1517\/13543784.2011.641532","volume":"21","author":"Gualberto A.","year":"2012","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"7","key":"ref3\/cit3b","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40265-013-0050-2","volume":"73","author":"Ballantyne A.","year":"2013","journal-title":"Drugs"},{"issue":"1","key":"ref4\/cit4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/bc010021y","volume":"13","author":"Hamann P. R.","year":"2002","journal-title":"Bioconjugate Chem."},{"issue":"6","key":"ref5\/cit5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00280-007-0560-2","volume":"61","author":"Boghaert E. R.","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"ref6\/cit6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1124\/jpet.103.060533","volume":"308","author":"Xie H.","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"ref7\/cit7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/bc7004329","volume":"19","author":"Alley S. C.","year":"2008","journal-title":"Bioconjugate Chem."},{"issue":"10","key":"ref8\/cit8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/bc200148v","volume":"22","author":"Baldwin A. D.","year":"2011","journal-title":"Bioconjugate Chem."},{"issue":"2","key":"ref9\/cit9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","volume":"30","author":"Shen B.-Q.","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref10\/cit10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-62703-541-5_9","volume":"1045","author":"Stefano James E.","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref11\/cit11","unstructured":"Doroski, M. D., Maderna, A., O\u2019Donnell, C. J., Subramanyam, C., Vetelino, B. C., Dushin, R. G., Strop, P., and Graziani, E. I.(Pfizer)Cytotoxic peptides and antibody drug conjugates thereof. Pat. Appl. No. WO 2013\/072813 A2, reference document 20121107, May 23, 2013."},{"key":"ref12\/cit12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1158\/1078-0432.843.11.2","volume":"11","author":"Sanderson R. J.","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"ref13\/cit13","doi-asserted-by":"crossref","first-page":"e83865\/1","DOI":"10.1371\/journal.pone.0083865","volume":"9","author":"Jackson D.","year":"2014","journal-title":"PLoS One"},{"issue":"20","key":"ref14\/cit14","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","volume":"10","author":"Hamblett K. J.","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"48","key":"ref15\/cit15a","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1002\/anie.201306241","volume":"52","author":"Toda N.","year":"2013","journal-title":"Angew. Chem., Int. Ed."},{"issue":"3","key":"ref15\/cit15b","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/bc400245v","volume":"25","author":"Badescu G.","year":"2014","journal-title":"Bioconjugate Chem."},{"key":"ref15\/cit15c","doi-asserted-by":"crossref","unstructured":"cLyon, R., Setter, J., Bovee, T., Doronina, S., Hunter, J., Anderson, M., Balasubramanian, C., Duhino, S., Lieske, C., Li, F., and Senter, P.Self-stabilizing maleimides improve the stabilty and pharmacological properties of antibody-drug-conjugates.Nat. Biotechnol. 2014, in press","DOI":"10.1038\/nbt.2968"}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/bc500357n","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T04:39:42Z","timestamp":1680842382000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/bc500357n"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,6]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10,15]]}},"alternative-id":["10.1021\/bc500357n"],"URL":"https:\/\/doi.org\/10.1021\/bc500357n","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,6]]}}}